Blood Meriranta, L, Alkodsi, A, Pasanen, A, Lepistö, M, Mapar, P, Blaker, Y N, Jørgensen, J M, Karjalainen-Lindsberg, M-L, Fiskvik, I, Mikalsen, L T G, Autio, M, Björkholm, M, Jerkeman, M, Fluge, Ø, Brown, P, Jyrkkiö, S, Holte, H, Pitkänen, E, Ellonen, P & Leppa, S 2022, ' Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma ', Blood, vol. 139, no. 12, pp. 1863-1877 . https://doi.org/10.1182/blood.2021012852
Jerkeman, M, Kolstad, A, Hutchings, M, Pasanen, A, Meriranta, L, Niemann, C U, Jorgensen, R R K, El-Galaly, T C C, Riise, J, Leppä, S, Christensen, J H, Wader, K F & Glimelius, I 2022, ' Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma-the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial ', Blood, vol. 140, no. Suppl. 1, 623, pp. 184–185 . https://doi.org/10.1182/blood-2022-155654